Polar Asset Management Partners’s ZyVersa Therapeutics ZVSA Stock Holding History

Polar Asset Management Partners’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-143	Closed	-$500K	–	1330
2022 Q3	$500K	Hold	143	–	–	0.01%	812
2022 Q2	$496K	Buy	+143	New	+$497K	0.01%	798

Other funds holding ZVSA

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Polar Asset Management Partners's ZVSA Position: Q4 2022 in Review

Polar Asset Management Partners sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 143 shares — an estimated $500K sold.

Polar Asset Management Partners first reported a position in ZVSA in Q2 2022 and held it in 2 quarters. The position peaked at $500K in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

Polar Asset Management Partners reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
Polar Asset Management Partners sold 143 ZyVersa Therapeutics shares in Q4 2022, an estimated $500K.
Polar Asset Management Partners first reported a position in ZyVersa Therapeutics in Q2 2022 and held it in 2 quarters.
Polar Asset Management Partners's ZyVersa Therapeutics position peaked at $500K in Q3 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on Polar Asset Management Partners's 13F filing for Q4 2022, filed 14 Feb 2023.